Transaction Search Form: please type in any of the fields below.
Date: April 30, 2024 Tue
Time: 12:24 am
Time: 12:24 am
Results for prescription drugs (wyoming)
1 results foundAuthor: Butler, Steve Title: Scheduled Prescription Drug Distribution in Wyoming: Analysis of the Wyoming Prescription Drug Monitoring Program 2004-2009 Summary: The Wyoming Survey & Analysis Center (WYSAC) at the University of Wyoming proposed this research project as part of the 2010 State Justice Statistics Program for Statistical Analysis Centers. Accepted projects were funded by the Bureau of Justice Statistics. The study examines statewide prescribing patterns of Schedule II and above drugs as recorded through the Wyoming Prescription Drug Monitoring Program (PDMP). PDMPs are databases that contain prescribing information of drugs that have high potential for abuse, such as opioids, benzodiazepines, stimulants, and barbiturates, among others (Schedule II and above). In Wyoming and other states, PDMPs have primarily been used to assist doctors and pharmacists in identifying patients who might be attaining illicit access to drugs through doctor-shopping and fraudulent prescription scams. Also helping states to understand legitimate scheduled drug prescribing, PDMPs analysis reveals the scale and scope of scheduled drug distribution, both geographically and over time. Testament of the usefulness of PDMPs is demonstrated through their proliferation throughout the U.S.: In 2002 only nineteen states had PDMPs and as of 10/2008 forty-seven states had such systems. In the 2002 United States General Accounting Office report, Prescription Drugs: State Monitoring Programs Provide Useful Tools to Reduce Diversion, the GAO asserted that PDMPs in some states were used to evaluate prescribing patterns in order to identify medical practitioners who are overprescribing. After identifying possible cases, PDMP officials inform doctors that their patterns are unrepresentative of the greater medical community, and thereby attempt to influence prescribing by educating practitioners. PDMPs also identify patients who are abusing or diverting prescription drugs for sale on the black-market and provide this information to doctors and pharmacists. Programs that educate physicians, pharmacies, and the public about the existence of diversion scams, along with the tactics employed, are constructive outcomes of the public dissemination of PDMP analyses. Once educated about diversion tactics, key stakeholders can become a substantial force in the prevention of abuse and diversion. For example, based on PDMP analysis in Nevada and Utah, physicians were sent drug utilization letters containing information that signaled potential diversion activity, including the number and types of drugs prescribed. Here in Wyoming, a RX Abuse Stakeholders was created in 2008 and is chaired by the U.S. Attorney’s Office. Representatives from health care, government, law enforcement and community members serve on the taskforce. The mission is to prevent the increasing abuse of prescription medications while ensuring that they remain available for patients in need. Methods of advancement include educating healthcare professionals, law enforcement and the general public about use and abuse of scheduled drugs, and strengthening the regulatory framework. The Wyoming State Board of Pharmacy manages the PDMP and according to Wyoming statute, legitimate uses of the system include: “release of information to practitioners and pharmacists when the release of the information may be of assistance in preventing or avoiding inappropriate use of controlled substances; The board shall report any information that it reasonably suspects may relate to fraudulent or illegal activity to the appropriate law enforcement agency and the relevant occupational licensing board and the board may release data for educational, research or public information purposes” (W.S 35-7-1060). Data for this study consists of all Wyoming PDMP records from 2004 through 2009. Prior to this project, no comprehensive study has been conducted on the distribution of prescribed Schedule II, III, and IV drugs as recorded in the Wyoming PDMP. Details: Laramie, WY: Wyoming Survey & Analysis Center, University of Wyoming, 2011. 307p. Source: Internet Resource: WYSAC Technical Report No. CJR-1007: Accessed May 4, 2012 at: https://wysac.uwyo.edu/ReportView.aspx?DocId=479&A=1 Year: 2011 Country: United States URL: https://wysac.uwyo.edu/ReportView.aspx?DocId=479&A=1 Shelf Number: 125158 Keywords: Prescription Drug AbusePrescription Drugs (Wyoming)Prescription Fraud |